GlassScriptPhysician profile
Anthony James Canfield
NPI 1588626642
$854,071.78
in general payments reported to CMS, 2019-2025
24 companies · $138K in 2025
The $138K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166K · 2020: $86K · 2021: $92K · 2022: $107K · 2023: $154K · 2024: $110K · 2025: $138K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $144K · Honoraria: $130K · Travel and Lodging: $60K · Consulting Fee: $29K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $14K · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $144,100.00 |
| Honoraria | $129,825.00 |
| Travel and Lodging | $60,039.05 |
| Consulting Fee | $29,350.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,100.00 |
| Food and Beverage | $14,271.91 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $474,038.60 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Davol INC. | $333,557.08 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Aroa Biosurgery Incorporated | $26,171.02 | 2022-2025 | |
| Covidien LP | $8,794.30 | 2019 | |
| Medtronic, INC. | $2,651.94 | 2021-2022 | |
| Bolder Surgical LLC | $1,400.00 | 2020 | |
| Ethicon US, LLC | $1,296.46 | 2019-2025 | Vistaseal, Stratafix, Evarrest |
| Acell, INC. | $1,221.10 | 2019-2020 | |
| Avanos Medical | $1,203.44 | 2019-2025 | On-Q Pump and Accessories, On-Q* Pump and Accessories, Quikbloc |
| Becton, Dickinson and Company | $1,150.74 | 2023-2025 | Phasix Mesh, Channel Drain, Hemosphere |
| C. R. Bard, INC. & Subsidiaries | $633.75 | 2019-2022 | |
| Stryker Corporation | $534.63 | 2019 | |
| Karl Storz Endoscopy-America | $372.84 | 2019-2023 | |
| Medical Device Business Services, INC. | $305.00 | 2019 | |
| Tela Bio, INC. | $274.17 | 2020-2024 | Ovitex 2s |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $107.93 | 2019 | |
| Dilon Technologies, INC. | $93.55 | 2024 | Hemoblast Bellows |
| Conmed Corporation | $70.76 | 2019-2024 | Airseal, Abc Handpieces, Visiclear |
| Hologic Sales and Service, LLC | $52.84 | 2025 | Coolseal Generator |
| Heron Therapeutics, INC. | $43.87 | 2022 | |
| Kci USA, INC. | $32.76 | 2019-2021 | |
| Teleflex LLC | $26.47 | 2022 | |
| Ethicon INC. | $23.37 | 2025 | N/A, Ethibond Excel |
| Edwards Lifesciences Corporation | $15.16 | 2024 | Hemosphere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Canfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.